Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)
Close on Nov 17, 2026Market cap $424.04MP/E –Yield –
Prothena Corp Public market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Prothena Corp Public's market cap was $451.73M on Nov 11, 2026, against $578.67M a year earlier. Over the last 5 years it ranged from $247.07M to $3.63B, with a median of $1.20B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $451.73M | -12.1% |
| 2025 | Dec 31, 2025 | $514.08M | -31.0% |
| 2024 | Dec 31, 2024 | $745.25M | -61.8% |
| 2023 | Dec 29, 2023 | $1.95B | -32.4% |
| 2022 | Dec 30, 2022 | $2.89B | +25.5% |
| 2021 | Dec 31, 2021 | $2.30B | +379.4% |
| 2020 | Dec 31, 2020 | $479.46M | -24.1% |
| 2019 | Dec 31, 2019 | $631.56M | +53.8% |
| 2018 | Dec 31, 2018 | $410.60M | -71.5% |
| 2017 | Dec 29, 2017 | $1.44B | -15.0% |
| 2016 | Dec 30, 2016 | $1.69B | -21.1% |
| 2015 | Dec 31, 2015 | $2.15B | +277.7% |
| 2014 | Dec 31, 2014 | $568.44M | +21.2% |
| 2013 | Dec 31, 2013 | $468.85M | +341.2% |
| 2012 | Dec 31, 2012 | $106.26M | – |
See a number that looks wrong?